Thomas Wenker, MD
Dermatology · Westerville, OHNPI 1194926014
Payments from drug & device makers
Across 172 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pfizer$427
- E.r. Squibb & Sons, L.L.C.$318
- Galderma Laboratories, L.p.$91
- Lilly USA, LLC$79
- Dermavant Sciences, Inc.$60
- plus $203 from 6 others
What the payments were for
- Food & beverage$3,20599%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 107 | $2,050 |
| Pfizer | 26 | $427 |
| E.r. Squibb & Sons, L.L.C. | 14 | $318 |
| Galderma Laboratories, L.p. | 5 | $91 |
| Lilly USA, LLC | 4 | $79 |
| Dermavant Sciences, Inc. | 4 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Amgen | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Johnson & Johnson | 1 | $21 |
| Biofrontera Inc. | 1 | $13 |
How this compares
$3,229 in reported general payments places this provider in the 55th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $82,470 |
| Dupixent PenDupilumab | 13 | $49,392 |
| Acitretin | 15 | $4,779 |
| Fluorouracil | 49 | $3,744 |
| Ketoconazole | 143 | $1,764 |
| Clobetasol Propionate | 35 | $1,536 |
| Tacrolimus | 13 | $1,417 |
| Metronidazole | 30 | $1,399 |
| Fluocinonide | 26 | $934 |
| Desonide | 26 | $843 |
| Triamcinolone Acetonide | 97 | $608 |
| Clindamycin Phosphate | 15 | $561 |
| Betamethasone Dipropionate | 16 | $492 |
| Doxycycline Hyclate | 26 | $469 |
| ValacyclovirValacyclovir Hcl | 16 | $164 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Westerville
- Jennifer NashWesterville$4M
- Jess DemariaWesterville$813K
- Joshua GrosshandlerWesterville$479K
- Kevin DonnellyWesterville$353K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jeffrey TraversDayton$4.7M
- Jessica KaffenbergerColumbus$3.2M
- Rocco SerraoDayton$3M
- Patrick ShannonBoardman$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.